Á lódáil...
Commentary Regarding Shapiro, “Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?”
The FDA recently expanded the approved use of Dexcom’s G5 Mobile continuous glucose monitoring (CGM) system to allow for diabetes treatment decisions. This decision is expected to reduce the burden of SMBG testing and increase the adoption and persistent use of CGM. The safety of nonadjunctive CGM u...
Na minha lista:
| Foilsithe in: | J Diabetes Sci Technol |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
SAGE Publications
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5588837/ https://ncbi.nlm.nih.gov/pubmed/28654305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817695341 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|